Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00111462
NCT00111462
View on ClinicalTrials.gov
Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy
PHASE2
Completed
INTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Anemia
Non-Myeloid Malignancies
Cancer
Interventions
DRUG
Darbepoetin alfa
Sponsors
Lead Sponsor
Amgen
All Listed Sponsors
lead
Amgen
INDUSTRY
NCT00111462 - Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy | Biotech Hunter | Biotech Hunter